Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Satisfaction With Communication in Everyday Speaking Situations (Scess) Scale: An Overarching Outcome Measure of Treatment Effect Publisher Pubmed



Karimi H1, 6 ; Onslow M1, 7 ; Jones M2 ; Obrian S1, 7 ; Packman A1, 7 ; Menzies R1, 7 ; Reilly S3 ; Sommer M4 ; Jelcicjaksic S5
Authors
Show Affiliations
Authors Affiliations
  1. 1. The University of Sydney, Faculty of Health Science, Australian Stuttering Research Centre, PO Box 170, Lidcombe, Sydney, 1825, NSW, Australia
  2. 2. School of Public Health, University of Queensland, Level 2, Public Health Building, Herston Road, Herston, 4006, QLD, Australia
  3. 3. Griffith University, Australia
  4. 4. Department of Clinical Neurophysiology, University Medical Center Gottingen, Germany
  5. 5. The Children's Hospital Zagreb, Croatia
  6. 6. Communication Disorders Research Center, Isfahan University of Medical Sciences, Isfahan Province, Iran
  7. 7. Australian Stuttering Research Centre, University of Technology Sydney, Ultimo, Australia

Source: Journal of Fluency Disorders Published:2018


Abstract

Purpose: The Consolidated Standards of Reporting Trials (CONSORT) statement strongly suggests one primary outcome for clinical trials, yet the outcomes of stuttering treatments span numerous behavioral and psychosocial domains. That presents a roadblock to eventual meta-analysis of clinical trials for adults who stutter. Method: We propose a simple and convenient outcome measure for clinical trials of stuttering treatment for adults that spans whatever behavioral and psychosocial factors might impel clients to seek treatment: a nine-point scale of Satisfaction with Communication in Everyday Speaking Situations (SCESS). The scale consists of one question which is simple, brief, easy to administer, cost-free, and translatable into many languages. The present report develops the SCESS scale by determining its reliability, content validity, and construct validity. Results: Reliability, content validity, and construct validity of the SCESS were confirmed with statistically significant and substantive correlations with speech-related and anxiety-related measures. However, the SCESS did not correlate well with percentage syllables stuttered. Three behavioral and psychosocial measures had the highest correlation with the SCESS: total Overall Assessment of the Speaker's Experience of Stuttering, self-reported stuttering severity, and Unhelpful Thoughts and Beliefs about Stuttering. Conclusion: The SCESS measure has potential to be applied as an overarching clinical trial outcome measure of stuttering treatment effect. This study provides some preliminary evidence for including it as a primary or secondary outcome in clinical trials of adult stuttering treatments. However, further studies are needed to establish the SCESS responsiveness to different stuttering treatments. © 2018 Elsevier Inc.
Experts (# of related papers)
Other Related Docs
16. Olanzapine Versus Haloperidol: Which Can Control Stuttering Better?, International Journal of Preventive Medicine (2013)
22. Efficacy of Levetiracetam in Treatment of Childhood Stuttering, International Journal of Preventive Medicine (2020)